Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled TrialThomas J. Walsh, John R. Perfect, Gerald R. Donowitz et al.|Clinical Infectious Diseases|2006Cited by 752
Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal InfectionAndrew J. Ullmann, Issam Raad, Oliver A. Cornely et al.|Antimicrobial Agents and Chemotherapy|2006Cited by 273